Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,293 | 30,858 | 42,299 | 138,875 | 27,704 |
| Marketable Securities | 129,914 | 144,570 | 154,666 | 74,937 | 81,597 |
| Other current assets | 693 | 522 | 451 | 479 | 2,051 |
| TOTAL | $166,151 | $179,389 | $200,163 | $217,940 | $115,462 |
| Non-Current Assets | |||||
| PPE Net | 749 | 691 | 375 | 347 | 298 |
| Other Non-Current Assets | 2,914 | 3,085 | 3,171 | 2,918 | 2,442 |
| TOTAL | $3,663 | $3,776 | $3,546 | $3,265 | $2,740 |
| Total Assets | $169,814 | $183,165 | $203,709 | $221,205 | $118,202 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,061 | 2,538 | 2,329 | 3,731 | 2,392 |
| Accrued Expenses | 17,039 | 11,560 | 11,018 | 10,320 | 14,150 |
| TOTAL | $21,388 | $14,386 | $13,636 | $14,339 | $16,830 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,585 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 288 | 288 | 289 | 288 | N/A |
| Other Non-Current Liabilities | 938 | 1,060 | 1,208 | 2,275 | 2,460 |
| TOTAL | $6,528 | $2,137 | $2,357 | $2,275 | $2,460 |
| Total Liabilities | $27,916 | $16,523 | $15,993 | $16,614 | $19,290 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,464 | 27,927 | 25,913 | 21,722 | 9,587 |
| Common Shares | 285 | 272 | 239 | 194 | 86 |
| Retained earnings | -413,484 | -383,993 | -358,300 | -329,354 | -315,311 |
| Other shareholders' equity | 102,401 | 111,176 | 133,676 | 161,460 | 154,351 |
| TOTAL | $141,898 | $166,642 | $187,716 | $204,591 | $98,912 |
| Total Liabilities And Equity | $169,814 | $183,165 | $203,709 | $221,205 | $118,202 |